What is IQVIA's profit forecast for 2026?

IQVIA Holdings forecasts its 2026 adjusted earnings to be in the range of $12.55 to $12.85 per share, which is below analyst expectations.

How did IQVIA perform in the fourth quarter?

In the fourth quarter ended December 31, IQVIA reported an adjusted profit of $3.42 per share and revenue of $4.36 billion, both of which surpassed analyst estimates.

Home / Business and Economy / IQVIA Forecasts Profit Dip Amid Rising Costs

IQVIA Forecasts Profit Dip Amid Rising Costs

Q: Why is IQVIA's profit forecast below expectations?

The lower profit forecast is largely due to a projected increase of nearly $80 million in interest expenses related to financing activities and expected refinancing.

5 Feb

•

Summary

IQVIA predicts 2026 profit below expectations.
Higher interest expenses significantly impact earnings forecast.
Despite challenges, fourth-quarter results surpassed estimates.

IQVIA Forecasts Profit Dip Amid Rising Costs

IQVIA Holdings anticipates its 2026 adjusted earnings per share to range between $12.55 and $12.85, falling short of the consensus estimate. This outlook is attributed to a projected increase of nearly $80 million in interest expenses stemming from financing completed in 2025 and anticipated refinancing in 2026.

Despite these headwinds, IQVIA reported strong fourth-quarter results for the period ending December 31. The company's adjusted profit per share was $3.42, surpassing the estimated $3.40, with revenue reaching $4.36 billion, also exceeding expectations of $4.24 billion. The research & development solutions unit, a key area for clinical trial services, also posted revenue of $2.33 billion, outperforming estimates.